Healthy Plasma - Human plasma collected from IRB-consented, clinically screened healthy donors and processed within one day of collection, in the anticoagulant your assay requires. Ideal as matched control material for protein, metabolite, and inflammatory marker comparison against disease states, and for coagulation, cell-free nucleic acid, and immunoassay method development. Bulk plasma is available.
IRB-approved
Worldwide shipping
Full donor metadata
plasma
In Stock Samples
Lot #
Condition
Volume
Race/Ethnicity
Age
Gender
Country of Collection
Medications
Vials
Price
Action
80607
Normal (Healthy)
1.0 ML
Caucasian
28
Male
United States
No medications
14
$132.00
80707
Normal (Healthy)
1.0 ML
Caucasian
45
Female
United States
21
$132.00
80707
Normal (Healthy)
1.0 ML
Caucasian
45
Female
United States
1
$132.00
80607
Normal (Healthy)
1.0 ML
Caucasian
28
Male
United States
No medications
1
$132.00
80631
Normal (Healthy)
1.0 ML
Caucasian
37
Male
United States
Vitamin B Fluoxetine Bupropion Minoxidil Fluoxetine Raloxifene Estradiol injections from patches 25mg of Seroquel most nights
12
$132.00
80635
Normal (Healthy)
1.0 ML
Caucasian
29
Male
United States
Fish Oil/QD Vitamin D/QD Vitamin K2/QD Vitamin B12/QD
Vitamin B Fluoxetine Bupropion Minoxidil Raloxifene Estradiol 25mg of Seroquel most nights
2
$132.00
74719
Normal (Healthy)
1.0 ML
Hispanic/Latino
44
Male
United States
1
$132.00
71752
Normal (Healthy)
1.0 ML
African American
41
Female
United States (US)
5
$132.00
Healthy Human Plasma for Control and Baseline Research
Healthy Plasma is collected from IRB-consented, clinically screened healthy donors and processed within one day of collection to preserve key analytes such as cytokines, proteins, and metabolites. It supports research into inflammatory pathways, immune profiling, and biomarker discovery as matched control material. Anticoagulant type and aliquot volume are configured per project and reported per lot. Bulk plasma is available.
Why Plasma from Healthy Donors
Plasma is the fluid fraction of anticoagulated blood, separated by centrifugation without allowing the blood to clot. That distinction from serum is not cosmetic; it determines which analytes survive and which assays the specimen is fit for.
Because coagulation is prevented, fibrinogen and the clotting factors remain intact, making plasma the required matrix for coagulation and fibrinolysis research.
No clot forms, so platelets are not activated during processing and platelet-derived mediators are not released into the fluid — a major source of artefact when serum is used for cytokine and growth factor measurement.
Plasma is the conventional matrix for circulating cell-free nucleic acid and extracellular vesicle research, where cellular lysis during clotting would contaminate the analyte of interest.
Anticoagulant choice is part of the experimental design: EDTA chelates divalent cations and is standard for nucleic acid work, citrate is used for coagulation testing, and heparin is used where downstream enzymatic activity must be preserved. Specifying the tube up front avoids an unusable specimen.
Healthy plasma defines the baseline against which a disease-state signal is measured; without an identically collected and processed control arm, apparent biomarker differences may reflect pre-analytical handling rather than biology.
Because our healthy and disease-state collections run under the same protocols and processing windows, pre-analytical variables are held constant across the comparison.
Donor Stratification Available
Age band and sex assigned at birth, for demographic matching to a disease cohort
Race and ethnicity
Body mass index and smoking status where captured
Medication-free donors, or donors on defined medication classes
Blood type and infectious disease screening results, including viral serostatus where documented
Anticoagulant type, where inventory permits
Cohorts demographically matched to a specific disease-state collection available on request
Product Features
Research Use Only (RUO)
Plasma collected from clinically screened healthy donors
Processed within one day of collection
IRB-approved protocols and informed consent
Anticoagulant type specified at order where inventory permits
Custom aliquot volumes available upon request
Volumes and lot-specific processing details reported per lot
De-identified Donor Data
Verified healthy status following clinical screening
Demographic data: age, sex assigned at birth, race/ethnicity
Donor-reported medications and allergies
Additional demographic and screening metadata available on request
Applications
Matched control arms for disease-state biomarker discovery and validation
Cytokine, chemokine, and inflammation profiling
Proteomic and metabolomic baseline characterisation
Coagulation and fibrinolysis research with citrate collection
Circulating cell-free nucleic acid and extracellular vesicle method development
Immunoassay development, calibration, and matrix effect testing
Reference range and normal distribution establishment for candidate analytes
Controls for therapeutic candidate screening and pharmacokinetic method validation
Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
Documentation support available for regulatory review
Ordering & Customization
Healthy plasma is available in standard and custom volumes. For pricing, availability, international orders, or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations. To browse other donor cohorts and collection formats, visit our human plasma page.
Protocols & Documentation
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.